GOP Postpones Vote to Use Disease-Prevention Money to Extend Coverage for High-risk Patients

On the first full day of conference activity at AMCP 2023, a morning session examined prior authorization (PA) through a lens of refining the current process and the potential role of clinical trial data in PA criteria.

On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.

Recent papers highlight possible role of inflammation in connections between COVID-19, cancer markers.

On this episode of Managed Care Cast, we speak with Jennifer Schneider, MD, co-founder and chief executive officer of Homeward, a value-based care provider aiming to improve access to high-quality care in rural communities through tech-enabled clinical services, partnerships with local physicians and health plans, and community-level demographic data.

The survival benefits of immune checkpoint inhibitors varied in young patients versus older patients with advanced non–small-cell lung cancer, a recent study found.

The US organ transplant system might face an overhaul in a proposal to be announced on Wednesday after years of criticism; the FDA may decide whether to approve additional COVID-19 booster vaccinations for vulnerable populations; a new study finds the same, small breast cancer risk in multiple forms of hormonal birth control.